Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancer.
Liu B, Hu ZY, Xie N, Liu L, Li J, Yang X, Xiao H, Zhao X, Tian C, Wu H, Lu J, Gao J, Hu X, Cao M, Shui Z, Tang Y, Ouyang Q.
Liu B, et al. Among authors: hu zy.
Cancer Innov. 2024 Oct 25;3(6):e143. doi: 10.1002/cai2.143. eCollection 2024 Dec.
Cancer Innov. 2024.
PMID: 39464426
Free PMC article.